| pubmed-article:8846249 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0035330 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C1299003 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0040233 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0487742 | lld:lifeskim |
| pubmed-article:8846249 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:8846249 | pubmed:issue | 215 | lld:pubmed |
| pubmed-article:8846249 | pubmed:dateCreated | 1996-10-24 | lld:pubmed |
| pubmed-article:8846249 | pubmed:abstractText | The purpose of this study was to determine whether timolol drops compared to placebo drops had a significant effect on retinal vessel width in ocular hypertensives. | lld:pubmed |
| pubmed-article:8846249 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8846249 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8846249 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8846249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8846249 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8846249 | pubmed:issn | 1395-3931 | lld:pubmed |
| pubmed-article:8846249 | pubmed:author | pubmed-author:SchwartzBB | lld:pubmed |
| pubmed-article:8846249 | pubmed:author | pubmed-author:LavinPP | lld:pubmed |
| pubmed-article:8846249 | pubmed:author | pubmed-author:TakamotoTT | lld:pubmed |
| pubmed-article:8846249 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8846249 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8846249 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8846249 | pubmed:pagination | 41-53 | lld:pubmed |
| pubmed-article:8846249 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:meshHeading | pubmed-meshheading:8846249-... | lld:pubmed |
| pubmed-article:8846249 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8846249 | pubmed:articleTitle | Increase of retinal vessel width in ocular hypertensives with timolol therapy. | lld:pubmed |
| pubmed-article:8846249 | pubmed:affiliation | Tufts University School of Medicine, Boston, MA, USA. | lld:pubmed |
| pubmed-article:8846249 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8846249 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8846249 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8846249 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8846249 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
